These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7717375)

  • 21. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation for sickle cell disease. The United States experience.
    Johnson FL; Mentzer WC; Kalinyak KA; Sullivan KM; Abboud MR
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):22-6. PubMed ID: 8311168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis.
    Nietert PJ; Abboud MR; Silverstein MD; Jackson SM
    Blood; 2000 May; 95(10):3057-64. PubMed ID: 10807769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of chronic rhinosinusitis in patients affected by β-thalassemia major and sickle cell anaemia post allogenic bone marrow transplant.
    Martino F; Di Mauro R; Paciaroni K; Gaziev J; Alfieri C; Greco L; Floris R; Di Girolamo S; Di Girolamo M
    Int J Pediatr Otorhinolaryngol; 2018 Mar; 106():35-40. PubMed ID: 29447888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic cellular gene therapy in hemoglobinopathies--evaluation of hematopoietic SCT in sickle cell anemia.
    Lucarelli G; Gaziev J; Isgrò A; Sodani P; Paciaroni K; Alfieri C; De Angelis G; Marziali M; Simone MD; Gallucci C; Roveda A; Saltarelli F; Torelli F; Andreani M
    Bone Marrow Transplant; 2012 Feb; 47(2):227-30. PubMed ID: 21499319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
    Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
    Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiitis of the central nervous system after allogeneic bone marrow transplantation?
    Padovan CS; Bise K; Hahn J; Sostak P; Holler E; Kolb HJ; Straube A
    Stroke; 1999 Aug; 30(8):1651-6. PubMed ID: 10436117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography.
    Wiznitzer M; Ruggieri PM; Masaryk TJ; Ross JS; Modic MT; Berman B
    J Pediatr; 1990 Oct; 117(4):551-5. PubMed ID: 2213377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow.
    Neudorf SM; Rybka W; Ball E; Blatt J; Bloom E; Corey S; deMagalhaes-Silverman M; Koehler M; Lister J; Mierski J; Mirro J; Pincus S; Wilson J; Wollman M; Donnenberg AD
    J Hematother; 1997 Aug; 6(4):351-9. PubMed ID: 9377073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation in sickle cell disease: the Belgian experience.
    Vermylen C; Cornu G; Ferster A; Ninane J; Sariban E
    Bone Marrow Transplant; 1993; 12 Suppl 1():116-7. PubMed ID: 8374550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin.
    Ayas M; Solh H; Mustafa MM; Al-Mahr M; Al-Fawaz I; Al-Jefri A; Shalaby L; Al-Nasser A; Al-Sedairy R
    Bone Marrow Transplant; 2001 Jan; 27(2):139-43. PubMed ID: 11281382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMT for severe aplastic anemia using cyclosporine.
    May WS; Sensenbrenner LL; Burns WH; Ambinder R; Carroll MP; Griffin CA; Jones RJ; Miller CB; Mellits ED; Vogelsang GB
    Bone Marrow Transplant; 1993 Jun; 11(6):459-64. PubMed ID: 8334426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebrovascular accidents in children with homozygous sickle cell anemia: report on three cases (author's transl)].
    Bégué P; Fauré C; Rousseau MC; Bonnet-Gadjos M; Lasfargues G
    Ann Med Interne (Paris); 1981; 132(3):190-4. PubMed ID: 7294586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
    Zwaan CM; Van Weel-Sipman MH; Fibbe WE; Oudshoorn M; Vossen JM
    Bone Marrow Transplant; 1998 Mar; 21(5):447-53. PubMed ID: 9535036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
    Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
    Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.